Journal
JOURNAL OF TRANSPLANTATION
Volume 2011, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2011/750836
Keywords
-
Categories
Funding
- National Health and Medical Research Council Medical/Dental Post-graduate Research Scholarship
- Lions Medical Research Fellowship
- Queensland Government Health Research Fellowship
- National Health and Medical Research Council Project [511109]
- Amgen-Transplantation Society of Australia
- New Zealand Research Grant
Ask authors/readers for more resources
The incidence of BK virus infection in kidney transplant recipients has increased over recent decades, coincident with the use of more potent immunosuppression. More importantly, posttransplant BK virus replication has emerged as an important cause of graft damage and subsequent graft loss. Immunosuppression has been accepted as a major risk for BK virus replication. However, the specific contribution of individual immunosuppressive medications to this risk has not been well established. The purpose of this paper is to provide an overview of the recent literature on the influence of the various immunosuppressant drugs and drug combinations on posttransplant BK virus replication. Evidence supporting the various immunosuppression reduction strategies utilised in the management of BK virus will also be briefly discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available